The changing face of treatment for Crohn's diseaseVERMEIRE, S; RUTGEERTS, P.British journal of surgery. 2006, Vol 93, Num 4, pp 385-386, issn 0007-1323, 2 p.Article

FISH analysis of Lactobacillus biofilms in the gastrointestinal tract of different hostsLEBEER, S; VERHOEVEN, T. L. A; CLAES, I. J. J et al.Letters in applied microbiology. 2011, Vol 52, Num 3, pp 220-226, issn 0266-8254, 7 p.Article

JC viral loads in patients with Crohn's disease treated with immunosuppression : can we screen for elevated risk of progressive multifocal leukoencephalopathy? CommentaryCLIFFORD, David B; VERBEECK, J; VAN RANST, M et al.Gut. 2008, Vol 57, Num 10, issn 0017-5749, 1347-1349, 1393-1397 [8 p.]Article

Recent advances in clinical prac t ice oratory markers in ibd : Magic, or unnecessary toys?VERMEIRE, S; VAN ASSCHE, G; RUTGEERTS, P et al.Gut. 2006, Vol 55, Num 3, pp 426-431, issn 0017-5749, 6 p.Article

Review article : infliximab therapy for inflammatory bowel disease - seven years onRUTGEERTS, P; VAN ASSCHE, G; VERMEIRE, S et al.Alimentary pharmacology & therapeutics. 2006, Vol 23, Num 4, pp 451-463, issn 0269-2813, 13 p.Article

Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitisMARQUEZ, L; SHEN, C; HENCKAERTS, L et al.Gut. 2012, Vol 61, Num 4, pp 528-534, issn 0017-5749, 7 p.Article

A unique combination of celiac disease, mesenteric lymph node cavitation, splenic atrophy and necrotizing hepatitisCOMELIS, T; HIELE, M; VERMEIRE, S et al.Acta gastro-enterologica belgica (English ed.). 2008, Vol 71, Num 2, pp 267-270, issn 1784-3227, 4 p.Article

Review article : altering the natural history of crohn's disease -evidence for and against current therapiesVERMEIRE, S; VAN ASSCHE, G; RUTGEERTS, P et al.Alimentary pharmacology & therapeutics. 2007, Vol 25, Num 1, pp 3-12, issn 0269-2813, 10 p.Article

European evidence based consensus on the diagnosis and management of Crohn's disease : definitions an diagnosisSTANGE, E. F; TRAVIS, S. P. L; GASCHE, C et al.Gut. 2006, Vol 55, issn 0017-5749, i1-i15, SUP1Article

Review article : genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel diseaseVERMEIRE, S.Alimentary pharmacology & therapeutics. Supplement. 2006, Vol 24, Num 3, pp 2-10, issn 0953-0673, 9 p.Article

Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasisVERMEIRE, S; RUTGEERTS, P; VAN STEEN, K et al.Gut. 2004, Vol 53, Num 7, pp 980-986, issn 0017-5749, 7 p.Article

Tumour necrosis factor-α receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximabPIERIK, M; VERMEIRE, S; STEEN, K. V et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 3, pp 303-310, issn 0269-2813, 8 p.Article

Diagnostic approach to IBD : Inflammatory Bowel DiseaseVERMEIRE, S; PEETERS, M; RUTGEERTS, P et al.Hepato-gastroenterology. 2000, Vol 47, Num 31, pp 44-48, issn 0172-6390Article

Safety and cost of infliximab for the treatment of belgian pediatric patients with Crohn's diseaseDE GREEF, E; HOFFMAN, I; ARTS, W et al.Acta gastro-enterologica belgica (English ed.). 2012, Vol 75, Num 4, pp 425-431, issn 1784-3227, 7 p.Article

Outcome of surgery for rectovaginal fistula due to Crohn's diseaseRUFFOLO, C; PENNINCKX, F; VAN ASSCHE, G et al.British journal of surgery. 2009, Vol 96, Num 10, pp 1190-1195, issn 0007-1323, 6 p.Article

Azathioprine induced colitis : a case report and review of the literatureBOSSUYT, P; VERGAUWE, P; INDERADJAJA, N et al.Acta gastro-enterologica belgica (English ed.). 2007, Vol 70, Num 3, pp 302-305, issn 1784-3227, 4 p.Article

Validation of 16S rDNA sequencing in microdissected bowel biopsies from Crohn's disease patients to assess bacterial flora diversityDE HERTOGH, G; AERSSENS, J; GEBOES, K et al.Journal of pathology. 2006, Vol 209, Num 4, pp 532-539, issn 0022-3417, 8 p.Article

Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's diseasePIERIK, M; DE HERTOGH, G; VERMEIRE, S et al.Gut. 2005, Vol 54, Num 2, pp 223-227, issn 0017-5749, 5 p.Article

The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximabPERSOONS, P; VERMEIRE, S; RUTGEERTS, P et al.Alimentary pharmacology & therapeutics. 2005, Vol 22, Num 2, pp 101-110, issn 0269-2813, 10 p.Article

Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitisFRANCHIMONT, D; VERMEIRE, S; RUTGEERTS, P et al.Gut. 2004, Vol 53, Num 7, pp 987-992, issn 0017-5749, 6 p.Article

A positive response to infliximab in Crohn disease: Association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphismLOUIS, E; VERMEIRE, S; MALAISE, M et al.Scandinavian journal of gastroenterology. 2002, Vol 37, Num 7, pp 818-824, issn 0036-5521, 7 p.Article

Clustering of increased small intestinal permeability in families with Crohn's diseasePEETERS, M; GEYPENS, B; CLAUS, D et al.Gastroenterology (New York, NY. 1943). 1997, Vol 113, Num 3, pp 802-807, issn 0016-5085Article

Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapyBESSISSOW, T; RENARD, M; HOFFMAN, I et al.Alimentary pharmacology & therapeutics. 2012, Vol 36, Num 4, pp 312-323, issn 0269-2813, 12 p.Article

Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitisCLAES, I. J. J; LEBEER, Sarah; RUTGEERTS, P et al.Clinical and experimental immunology (Print). 2010, Vol 162, Num 2, pp 306-314, issn 0009-9104, 9 p.Article

SEVERITY (AND TREATMENT) OF CHRONIC LITHIUM POISONING: CLINICAL SIGNS OR LAB RESULTS AS A CRITERION?VERMEIRE, S; VANBRABANT, P; VAN BOXSTAEL, P et al.Acta clinica belgica (Ed. multilingue). 2010, Vol 65, Num 2, pp 127-128, issn 0001-5512, 2 p.Article